BEIJING--(BUSINESS WIRE)--China Medical Technologies, Inc. (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic systems and high intensity focused ultrasound (HIFU) products, and EDAP TMS S.A. (Nasdaq: EDAP), a global leader in HIFU treatment of prostate cancer, today announced an exclusive agreement in which EDAP will distribute China Medical’s HIFU tumor therapy systems in the European Union (EU) and Russia.
